Published in J Invest Dermatol on January 29, 2015
Transcriptional Analysis of Vitiligo Skin Reveals the Alteration of WNT Pathway: A Promising Target for Repigmenting Vitiligo Patients. J Invest Dermatol (2015) 1.52
A New View of Vitiligo: Looking at Normal-Appearing Skin. J Invest Dermatol (2015) 0.79
Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization. Med Res Rev (2016) 0.75
The epidermal polarity protein Par3 is a non-cell autonomous suppressor of malignant melanoma. J Exp Med (2017) 0.75
Aquaporin 3 and E-Cadherin Expression in Perilesional Vitiligo Skin. J Clin Diagn Res (2016) 0.75
Skin Pigmentation and Pigmentary Disorders: Focus on Epidermal/Dermal Cross-Talk. Ann Dermatol (2016) 0.75
Ecad vitiliGONE. Pigment Cell Melanoma Res (2015) 0.75
Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013) 6.13
Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways. Oncogene (2005) 5.50
E-cadherin null mutant embryos fail to form a trophectoderm epithelium. Proc Natl Acad Sci U S A (1994) 5.31
Filaggrin mutations associated with skin and allergic diseases. N Engl J Med (2011) 3.40
Clinical practice. Vitiligo. N Engl J Med (2009) 2.72
E-cadherin is a survival factor for the lactating mouse mammary gland. Mech Dev (2002) 2.63
4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2002) 2.38
Tissue organization by cadherin adhesion molecules: dynamic molecular and cellular mechanisms of morphogenetic regulation. Physiol Rev (2011) 2.06
IGF-II induces rapid beta-catenin relocation to the nucleus during epithelium to mesenchyme transition. Oncogene (2001) 2.03
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
Cre-mediated recombination in the skin melanocyte lineage. Genesis (2003) 1.69
In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc (1999) 1.58
Remodeling of the adherens junctions during morphogenesis. Curr Top Dev Biol (2009) 1.55
Autocrine and paracrine regulation of melanocytes in human skin and in pigmentary disorders. Pigment Cell Res (2004) 1.50
In vivo vitiligo induction and therapy model: double-blind, randomized clinical trial. Pigment Cell Melanoma Res (2011) 1.50
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res (2012) 1.48
Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else? Exp Dermatol (2008) 1.39
Beta-catenin inhibits melanocyte migration but induces melanoma metastasis. Oncogene (2012) 1.18
Melanocytes are not absent in lesional skin of long duration vitiligo. J Pathol (2000) 1.15
Vitiligo, reactive oxygen species and T-cells. Clin Sci (Lond) (2011) 1.14
Melanocytes as instigators and victims of oxidative stress. J Invest Dermatol (2014) 1.13
Genome-wide analysis identifies a quantitative trait locus in the MHC class II region associated with generalized vitiligo age of onset. J Invest Dermatol (2011) 1.08
Hydrogen peroxide-mediated oxidative stress disrupts calcium binding on calmodulin: more evidence for oxidative stress in vitiligo. Biochem Biophys Res Commun (2007) 1.04
Biological and mathematical modeling of melanocyte development. Development (2011) 1.02
DDR1 triggers epithelial cell differentiation by promoting cell adhesion through stabilization of E-cadherin. Mol Biol Cell (2011) 1.00
Association analyses identify three susceptibility Loci for vitiligo in the Chinese Han population. J Invest Dermatol (2012) 0.98
Innate immune mechanisms in vitiligo: danger from within. Curr Opin Immunol (2013) 0.97
Intrinsic and extrinsic pathomechanisms in vitiligo. Pigment Cell Res (2000) 0.97
Cytokine modulation of adhesion molecules in the regulation of immunologic cytotoxicity of epidermal targets. J Invest Dermatol (1990) 0.97
Major role of epidermal growth factor receptor and Src kinases in promoting oxidative stress-dependent loss of adhesion and apoptosis in epithelial cells. J Biol Chem (2009) 0.97
Reduced aquaporin3 expression and survival of keratinocytes in the depigmented epidermis of vitiligo. J Invest Dermatol (2010) 0.95
Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br J Dermatol (2003) 0.95
Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int J Dermatol (2009) 0.92
Role of keratinocytes in the development of vitiligo. Ann Dermatol (2012) 0.89
The melanocytorrhagic hypothesis of vitiligo tested on pigmented, stressed, reconstructed epidermis. Pigment Cell Res (2007) 0.87
Genetic variants of the DDR1 gene are associated with vitiligo in two independent Brazilian population samples. J Invest Dermatol (2010) 0.85
Keratinocytes act as a source of reactive oxygen species by transferring hydrogen peroxide to melanocytes. J Invest Dermatol (2005) 0.84
TNF-α promotes invasive growth through the MET signaling pathway. Mol Oncol (2014) 0.83
Koebner's phenomenon in vitiligo: European position paper. Pigment Cell Melanoma Res (2011) 0.83
Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients. Br J Dermatol (2011) 0.83
General strategy to analyse coat colour phenotypes in mice. Pigment Cell Melanoma Res (2011) 0.82
Study of CCN3 (NOV) and DDR1 in normal melanocytes and vitiligo skin. Exp Dermatol (2012) 0.80
Reduced immunohistochemical expression of Discoidin Domain Receptor 1 (DDR1) in vitiligo skin. J Eur Acad Dermatol Venereol (2012) 0.80
Inflammasome activation and vitiligo/nonsegmental vitiligo progression. Br J Dermatol (2014) 0.79
Endothelin-1 down-regulates E-cadherin in melanocytic cells by apoptosis-independent activation of caspase-8. J Am Acad Dermatol (2000) 0.79
Possible patterns of epidermal melanocyte disappearance in nonsegmental vitiligo: a clinicopathological study. Br J Dermatol (2014) 0.78
Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo/non-segmental vitiligo. Pigment Cell Melanoma Res (2013) 0.78